TPLS yields 4.49% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, TPLS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TPLS + JNJ for your $10,000?
TPLS builds a diversified fixed-income portfolio focused on total return through both income and capital appreciation. Investments include corporate bonds, government securities, MBS, ABS, and bank loans. The fund is flexible, allowing investments in securities of any credit quality and maturity. While it primarily invests in domestic issuers, it may also hold foreign debt, including obligations denominated in non-U.S. currencies, with foreign currency exposure limited to 25%. Additionally, the fund may allocate up to 25% of its assets to high-yield bonds, and exposure to emerging markets is capped at 15%. Security selection relies on fundamental research, which involves proprietary and third-party analysis to evaluate credit quality, economic trends, and valuation. Derivatives may also be used to enhance the portfolio or hedge risks. Positions may be sold to adjust duration, mitigate risk, or take advantage of more attractive opportunities.
Full TPLS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.